Senators Question HHS Nominees Alex Azar on Reducing Drug Prices
Yesterday morning, November 29th, the Senate Health, Education, Labor, and Pensions (HELP) Committee held its confirmation hearing on the...
Trump's Choice for Health Secretary Should Take Sweeping Action to Lower Drug Prices
This week President Trump announced his nomination of Alex Azar, a former pharmaceutical company executive, to be the next Secretary of...
Judge Denies Preliminary Injunction Against North Dakota Laws Regulating PBMs
Earlier this year, North Dakota passed two laws to regulated pharmacy benefit managers (PBMs) and curb their abuses. The laws were S.B....
Senator Klobuchar Criticizes Nomination of Alex Azar to Lead Health and Human Services, Calls For Ac
Yesterday evening Senator Amy Klobuchar (D-MN), one of the Senate's leading champions of reducing prescription drug prices, delivered an...
How Citizen Petitions Are Abused to Delay Generic Drug Access
The citizen petition process is provided by the Food and Drug Administration (FDA) to raise legitimate safety concerns about prescription...
John Oliver Looks at Antitrust Enforcement and Corporate Consolidation
In a recent segment, John Oliver looked at antitrust enforcement, and specifically at competition in the eyewear industry. He points out...
